Roche NimbleGen to Make Expression Arrays for High-Throughput Genomics

According to Roche, array supply deals like the one with HTG are part of the company's business strategy, and the firm is "currently in discussions with several customers to provide them with arrays specific to their needs."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.